Modification and Use of Naturally Renewable Cardanol-Type Prepolymers in One-Component Silyl-Terminated Prepolymer Sealant Systems.

The current research is devoted to integrating naturally renewable cardanol derivatives into one-component silyl-terminated-polyether-based prepolymer systems to improve climatic resistance and obtain materials with versatile mechanical properties that could be significant to various sectors of the economy. Various cardanol-type products are used in industries that require high climatic resistance, and thus combining cardanol with commercially available silyl-terminated polyether prepolymers would improve its material climatic resistance, maintaining its market and application value as well as improving material sustainability. The results obtained in this work show that depending on how the cardanol prepolymer Ultra Lite 513 is modified, it is possible to increase the elasticity (670%) or tensile strength (104%) of the material as well as significantly increase the climatic resistance of the material, thus improving the quality and sustainability of the adhesive compared to existing silyl-terminated-prepolymer-based adhesives on the market.

Melatonin signalling in Schwann cells during neuroregeneration.

It has widely been thought that in the process of nerve regeneration Schwann cells populate the injury site with myelinating, non-myelinating, phagocytic, repair, and mesenchyme-like phenotypes. It is now clear that the Schwann cells modify their shape and basal lamina as to accommodate re-growing axons, at the same time clear myelin debris generated upon injury, and regulate expression of extracellular matrix proteins at and around the lesion site. Such a remarkable plasticity may follow an intrinsic functional rhythm or a systemic circadian clock matching the demands of accurate timing and precision of signalling cascades in the regenerating nervous system.

Ghrelin Regulates Expression of the Transcription Factor Pax6 in Hypoxic Brain Progenitor Cells and Neurons.

The nature of brain impairment after hypoxia is complex and recovery harnesses different mechanisms, including neuroprotection and neurogenesis. Experimental evidence suggests that hypoxia may trigger neurogenesis postnatally by influencing the expression of a variety of transcription factors. However, the existing data are controversial.

Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial.

Background: Cobitolimod is a topically administered, DNA-based oligonucleotide that activates Toll-like receptor 9 (TLR9), and previous research has shown clinical efficacy in patients with moderate-to-severe ulcerative colitis. Here we assessed the efficacy and safety of different dose regimens of cobitolimod for induction therapy in patients with moderate-to-severe, left-sided ulcerative colitis.

Methods: CONDUCT was a randomised, double-blind, five-arm, placebo-controlled, dose-ranging phase 2b study that recruited patients with moderate-to-severe, left-sided ulcerative colitis, with inadequate response to conventional or biological therapies, from 91 hospitals or outpatient clinics in 12 European countries.

[Correction of early liver dysfunction in patients with acute small bowel obstruction].

Conducted a comprehensive examination and surgical treatment for acute obstruction of the small intestine (SI). It is established that, both before and after surgery to restore patency of SI is a significant violation of the functional state of the liver. This became the basis for the appointment of antioxidant therapy in the complex standard treatment.